BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 10425617)

  • 1. [Relationship between sympathetic activity and response to treatment with atenolol in hypertensive patients. Investigation group of the study of efficiency and tolerance of atenolol in hypertensive patients with increase in the sympathetic activity].
    de la Sierra A
    Med Clin (Barc); 1999 Jun; 113(2):41-5. PubMed ID: 10425617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of atrial fibrillation in relation to changing heart rate over time in hypertensive patients: the LIFE study.
    Okin PM; Wachtell K; Kjeldsen SE; Julius S; Lindholm LH; Dahlöf B; Hille DA; Nieminen MS; Edelman JM; Devereux RB
    Circ Arrhythm Electrophysiol; 2008 Dec; 1(5):337-43. PubMed ID: 19808428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term follow-up of ACE-inhibitor versus beta-blocker treatment and their effects on blood pressure and kidney function in renal transplant recipients.
    Suwelack B; Kobelt V; Erfmann M; Hausberg M; Gerhardt U; Rahn KH; Hohage H
    Transpl Int; 2003 May; 16(5):313-20. PubMed ID: 12759722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prazosin GITS vs atenolol in patients with hypertension and normal lipid profile: a randomized, controlled multicenter study. Hyderabad Hypertension Study Group.
    Joglekar SJ; Jaguste V; Nanivadekar AS
    J Assoc Physicians India; 1998; Suppl 1():41-51. PubMed ID: 11233386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention For End Point Reduction in Hypertension (LIFE) study.
    Wachtell K; Lehto M; Gerdts E; Olsen MH; Hornestam B; Dahlöf B; Ibsen H; Julius S; Kjeldsen SE; Lindholm LH; Nieminen MS; Devereux RB
    J Am Coll Cardiol; 2005 Mar; 45(5):712-9. PubMed ID: 15734615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sympathetic hypertensive syndrome: a possible surgically curable type of hypertension.
    Chou SH; Kao EL; Lin CC; Chuang HY; Huang MF
    Hypertens Res; 2005 May; 28(5):409-14. PubMed ID: 16156504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antihypertensive efficacy of indapamide SR in hypertensive patients uncontrolled with a background therapy: the NATIVE study.
    Akram J; Sheikh UE; Mahmood M; Donnelly R
    Curr Med Res Opin; 2007 Dec; 23(12):2929-36. PubMed ID: 17931463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Twenty-four-hour ambulatory blood pressure monitoring efficacy of perindopril/indapamide first-line combination in hypertensive patients: the REASON study.
    Mallion JM; Chamontin B; Asmar R; De Leeuw PW; O'Brien E; Duprez D; O'Rourke MF; Rahn KH; Romero R; Battegay E; Hitzenberger G; Safar ME;
    Am J Hypertens; 2004 Mar; 17(3):245-51. PubMed ID: 15001199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time-related effects of chronic atenolol treatment on cardiovascular responses to handgrip.
    Fogari R; Zoppi A; Orlandi C
    Int J Clin Pharmacol Ther Toxicol; 1985 Feb; 23(2):83-8. PubMed ID: 3988399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative evaluation of effect of valsartan/amlodipine and atenolol/amlodipine combinations on atrial fibrillation recurrence in hypertensive patients with type 2 diabetes mellitus.
    Fogari R; Zoppi A; Mugellini A; Corradi L; Lazzari P; Preti P; Derosa G
    J Cardiovasc Pharmacol; 2008 Mar; 51(3):217-22. PubMed ID: 18356684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism.
    Pessina AC; Ciccariello L; Perrone F; Stoico V; Gussoni G; Scotti A; Muggeo M
    Nutr Metab Cardiovasc Dis; 2006 Mar; 16(2):137-47. PubMed ID: 16487914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
    Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA
    J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood pressure reduction and antihypertensive medication use in the losartan intervention for endpoint reduction in hypertension (LIFE) study in patients with hypertension and left ventricular hypertrophy.
    Devereux RB; de Faire U; Fyhrquist F; Harris KE; Ibsen H; Kjeldsen SE; Lederballe-Pedersen O; Lindholm LH; Nieminen MS; Omvik P; Oparil S; Wedel H; Hille DA; Dahlöf B
    Curr Med Res Opin; 2007 Feb; 23(2):259-70. PubMed ID: 17288679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
    Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The clinical profile of hypertensive patients can predict the need for combining a second or third drug with atenolol in the initial treatment of light and moderate essential arterial hypertension].
    Coca A; de la Sierra A; Sobrino J; Aguilera MT; Lluch MM; Sánchez M; Picado MJ; Urbano-Márquez A
    Med Clin (Barc); 1990 Sep; 95(9):329-32. PubMed ID: 2280617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of doxazosin on ambulatory blood pressure and sympathetic nervous activity in hypertensive Type 2 diabetic patients with overt nephropathy.
    Yasuda G; Hasegawa K; Kuji T; Ogawa N; Shimura G; Umemura S; Tochikubo O
    Diabet Med; 2005 Oct; 22(10):1394-400. PubMed ID: 16176202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood pressure response under chronic antihypertensive drug therapy: the role of aortic stiffness in the REASON (Preterax in Regression of Arterial Stiffness in a Controlled Double-Blind) study.
    Protogerou A; Blacher J; Stergiou GS; Achimastos A; Safar ME
    J Am Coll Cardiol; 2009 Feb; 53(5):445-51. PubMed ID: 19179203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Role of vagosympathetic balance in obesity-induced hypertension].
    Dabiré H; Brahimi M; Hadj-Brahim F; Le Clésiau H; Attali JR; Valensi P
    Arch Mal Coeur Vaiss; 2004; 97(7-8):749-52. PubMed ID: 15506059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Relationship in cardiovascular reactivity to mental stress and early involvement of target organs in non-treated mild arterial hypertension. Hospitalet Study].
    Armario P; Hernández del Rey R; Torres G; Martín-Baranera M; Cruz Almendros M; Pardell H
    Med Clin (Barc); 1999 Oct; 113(11):401-6. PubMed ID: 10562950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salt supresses baseline muscle sympathetic nerve activity in salt-sensitive and salt-resistant hypertensives.
    Abrahão SB; Tinucci T; Santello JL; Mion D
    J Hum Hypertens; 2002 Dec; 16(12):843-50. PubMed ID: 12522465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.